P+F Products + Features GmbH gains CE Mark approval for TricValve® Transcatheter Bicaval Valves System
![Transcatheter Tricuspid Valve Interventions: Landscape, Challenges, and Future Directions - ScienceDirect Transcatheter Tricuspid Valve Interventions: Landscape, Challenges, and Future Directions - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109718346199-fx1.jpg)
Transcatheter Tricuspid Valve Interventions: Landscape, Challenges, and Future Directions - ScienceDirect
![TRICVALVE®: Transcatheter Bicaval Valves System granted Designation as Breakthrough Device by the U.S. Food and Drug Administration (FDA) | FDA Health News TRICVALVE®: Transcatheter Bicaval Valves System granted Designation as Breakthrough Device by the U.S. Food and Drug Administration (FDA) | FDA Health News](https://s3.amazonaws.com/jnswire/jns-media/68/8e/11511217/h.jpg)
TRICVALVE®: Transcatheter Bicaval Valves System granted Designation as Breakthrough Device by the U.S. Food and Drug Administration (FDA) | FDA Health News
![Challenges and future perspectives of transcatheter tricuspid valve interventions: adopt old strategies or adapt to new opportunities? - Russo - 2022 - European Journal of Heart Failure - Wiley Online Library Challenges and future perspectives of transcatheter tricuspid valve interventions: adopt old strategies or adapt to new opportunities? - Russo - 2022 - European Journal of Heart Failure - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/eba85b44-10e9-460f-8718-b63f3e0e9d33/ejhf2398-fig-0001-m.jpg)
Challenges and future perspectives of transcatheter tricuspid valve interventions: adopt old strategies or adapt to new opportunities? - Russo - 2022 - European Journal of Heart Failure - Wiley Online Library
![Manuel Barreiro-Perez on Twitter: "Expanding percutaneous structural heart portfolio on the tricuspid valve at Salamanca (#Mitraclip, DaVinghi TR, Tricentro, #TricValve). Great team work! @icruzgonzalez @jmmoreiras @manuelbarreirop @JeanNunezG ... Manuel Barreiro-Perez on Twitter: "Expanding percutaneous structural heart portfolio on the tricuspid valve at Salamanca (#Mitraclip, DaVinghi TR, Tricentro, #TricValve). Great team work! @icruzgonzalez @jmmoreiras @manuelbarreirop @JeanNunezG ...](https://pbs.twimg.com/media/ERJW4qOXUAAr-Q3.jpg)
Manuel Barreiro-Perez on Twitter: "Expanding percutaneous structural heart portfolio on the tricuspid valve at Salamanca (#Mitraclip, DaVinghi TR, Tricentro, #TricValve). Great team work! @icruzgonzalez @jmmoreiras @manuelbarreirop @JeanNunezG ...
![TricValve transcatheter bicaval valves system granted designation as Breakthrough Device by US Food and Drug Administration (FDA) - NS Medical Devices TricValve transcatheter bicaval valves system granted designation as Breakthrough Device by US Food and Drug Administration (FDA) - NS Medical Devices](https://www.nsmedicaldevices.com/wp-content/uploads/sites/2/2020/12/ID-100644109.jpg)
TricValve transcatheter bicaval valves system granted designation as Breakthrough Device by US Food and Drug Administration (FDA) - NS Medical Devices
P+F Products + Features GmbH gains CE Mark approval for TricValve® Transcatheter Bicaval Valves System, P+F Products and Features GmbH, Press release - PresseBox
![JCM | Free Full-Text | Caval Valve Implantation (CAVI): An Emerging Therapy for Treating Severe Tricuspid Regurgitation JCM | Free Full-Text | Caval Valve Implantation (CAVI): An Emerging Therapy for Treating Severe Tricuspid Regurgitation](https://www.mdpi.com/jcm/jcm-10-04601/article_deploy/html/images/jcm-10-04601-g002.png)
JCM | Free Full-Text | Caval Valve Implantation (CAVI): An Emerging Therapy for Treating Severe Tricuspid Regurgitation
![First Transcatheter TricValve System Implanted for Tricuspid Regurgitation in North America – Consult QD First Transcatheter TricValve System Implanted for Tricuspid Regurgitation in North America – Consult QD](https://consultqd.clevelandclinic.org/wp-content/uploads/sites/2/2022/03/22-HVI-2843464_transcatheter-bicaval-valves-system_650x450.jpg)
First Transcatheter TricValve System Implanted for Tricuspid Regurgitation in North America – Consult QD
![TRICVALVE®: Transcatheter Bicaval Valves System granted Designation as Breakthrough Device by the U.S. Food and Drug Administration (FDA) | FDA Reporter TRICVALVE®: Transcatheter Bicaval Valves System granted Designation as Breakthrough Device by the U.S. Food and Drug Administration (FDA) | FDA Reporter](https://s3.amazonaws.com/jnswire/jns-media/f6/1f/11511239/3valv.png)
TRICVALVE®: Transcatheter Bicaval Valves System granted Designation as Breakthrough Device by the U.S. Food and Drug Administration (FDA) | FDA Reporter
![Update on the Current Landscape of Transcatheter Options for Tricuspid Regurgitation Treatment | ICR Journal Update on the Current Landscape of Transcatheter Options for Tricuspid Regurgitation Treatment | ICR Journal](https://assets.radcliffecardiology.com/s3fs-public/article/2020-12/figure1-transcatheter-tricuspid.png)
Update on the Current Landscape of Transcatheter Options for Tricuspid Regurgitation Treatment | ICR Journal
![JCM | Free Full-Text | Caval Valve Implantation (CAVI): An Emerging Therapy for Treating Severe Tricuspid Regurgitation JCM | Free Full-Text | Caval Valve Implantation (CAVI): An Emerging Therapy for Treating Severe Tricuspid Regurgitation](https://www.mdpi.com/jcm/jcm-10-04601/article_deploy/html/images/jcm-10-04601-g001.png)